Landos Biopharma: Slumps in market debut

Landos Biopharma

04/02/2021 18:39

** Shares of Landos Biopharma Inc  LABP.O  fall nearly 19%
to open at $13 in their Nasdaq debut
    ** At the debut price, co is valued at around $509 mln
    ** Co's IPO was priced at $16 per share  urn:newsml:reuters.com:*:nGNXbHw35x
    ** It offered 6.25 mln shares in IPO, raising about $100 mln
    ** Blacksburg, VA-based Landos is a clinical-stage
biopharmaceutical company that develops therapies for the
treatment of autoimmune diseases 
    ** J.P. Morgan, Jefferies and SVB Leerink were the joint
book-running mangers for the offering

 (Reporting by Sohini Podder in Bengaluru)
 ((sohini.podder@thomsonreuters.com))